Literature DB >> 18823382

The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis.

D Calva-Cerqueira1, S Chinnathambi, B Pechman, J Bair, J Larsen-Haidle, J R Howe.   

Abstract

Juvenile polyposis (JPS) is an autosomal dominant syndrome that predisposes individuals to develop gastrointestinal polyps and cancer. Germline point mutations in SMAD4 and BMPR1A have been identified as causing JPS in approximately 40-60% of patients, but few studies have looked at the rate of large deletions. In this study, we determined the overall prevalence of genetic changes of SMAD4 and BMPR1A by sequencing and by screening for larger deletions. DNA was extracted from 102 JPS probands, and each exon and intron-exon boundary of SMAD4 and BMPR1A were sequenced. Coding and non-coding exons of SMAD4 and BMPR1A were screened for deletions with multiplex ligation-dependent probe amplification (MLPA). By sequencing, 20 probands had point mutations of SMAD4 and 22 of BMPR1A. By MLPA, one proband had deletion of most of SMAD4, one of both BMPR1A and PTEN, one of the 5' end of BMPR1A, and another of the 5' end of SMAD4. The overall prevalence of SMAD4 and BMPR1A point mutations and deletions in JPS was 45% in the largest series of patients to date. Large deletions are less frequent in JPS patients, but represent other heritable causes of JPS, which should be screened for in pre-symptomatic genetic testing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823382     DOI: 10.1111/j.1399-0004.2008.01091.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  35 in total

1.  Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation.

Authors:  Changqing Ma; Francis M Giardiello; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

Review 2.  Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23.

Authors:  F S Dahdaleh; J C Carr; D Calva; J R Howe
Journal:  Clin Genet       Date:  2011-09-06       Impact factor: 4.438

3.  Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling.

Authors:  Jennifer C Carr; Fadi S Dahdaleh; Donghong Wang; James R Howe
Journal:  J Surg Res       Date:  2011-11-30       Impact factor: 2.192

4.  BMPR1A mutations in juvenile polyposis affect cellular localization.

Authors:  James R Howe; Fadi S Dahdaleh; Jennifer C Carr; Donghong Wang; Scott K Sherman; James R Howe
Journal:  J Surg Res       Date:  2013-02-01       Impact factor: 2.192

5.  Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.

Authors:  Scott K Sherman; Jessica E Maxwell; Qining Qian; Andrew M Bellizzi; Terry A Braun; Mark D Iannettoni; Benjamin W Darbro; James R Howe
Journal:  Cancer Genet       Date:  2014-11-15

6.  SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice.

Authors:  Reka Szigeti; Stephanie A Pangas; Dorottya Nagy-Szakal; Scot E Dowd; Robert J Shulman; Anthony P Olive; Edwina J Popek; Milton J Finegold; Richard Kellermayer
Journal:  Ann Clin Lab Sci       Date:  2012       Impact factor: 1.256

Review 7.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

8.  Aggressive juvenile polyposis in children with chromosome 10q23 deletion.

Authors:  Seth Septer; Lei Zhang; Caitlin E Lawson; Jose Cocjin; Thomas Attard; Holly H Ardinger
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 9.  Clinical heterogeneity of mitochondrial NAD kinase deficiency caused by a NADK2 start loss variant.

Authors:  Daniel J Pomerantz; Sacha Ferdinandusse; Joy Cogan; David N Cooper; Tyler Reimschisel; Amy Robertson; Anna Bican; Tracy McGregor; Jackie Gauthier; David S Millington; Jaime L W Andrae; Michael R Tschannen; Daniel C Helbling; Wendy M Demos; Simone Denis; Ronald J A Wanders; John N Newman; Rizwan Hamid; John A Phillips
Journal:  Am J Med Genet A       Date:  2018-02-01       Impact factor: 2.802

Review 10.  Smad4-mediated TGF-beta signaling in tumorigenesis.

Authors:  Guan Yang; Xiao Yang
Journal:  Int J Biol Sci       Date:  2010-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.